Revenue Breakdown
Composition ()
No data
Revenue Streams
Ceribell Inc (CBLL) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is EEG headbands, point in time, accounting for 75.3% of total sales, equivalent to $17.02M. Another important revenue stream is EEG portal and Clarity subscriptions, over time. Understanding this composition is critical for investors evaluating how CBLL navigates market cycles within the Advanced Medical Equipment & Technology industry.
Profitability & Margins
Evaluating the bottom line, Ceribell Inc maintains a gross margin of 88.28%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -64.84%, while the net margin is -59.61%. These profitability ratios, combined with a Return on Equity (ROE) of -373.40%, provide a clear picture of how effectively CBLL converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, CBLL competes directly with industry leaders such as MDXG and SIBN. With a market capitalization of $748.59M, it holds a significant position in the sector. When comparing efficiency, CBLL's gross margin of 88.28% stands against MDXG's 83.44% and SIBN's 79.84%. Such benchmarking helps identify whether Ceribell Inc is trading at a premium or discount relative to its financial performance.
